“The IMPRoVED-AF study is an important validation of the meaningful impact vMap is already delivering in the EP lab. vMap is uncovering drivers that often go undetected, helping physicians deliver more effective and durable outcomes. This study is a critical part of our

By unlocking insights from a standard 12-lead ECG, vMap helps physicians identify arrhythmia sources faster, reduce overall procedure times, and overcome limitations, enabling the successful treatment of complex arrhythmias. For patients, that means fewer procedures, less

"BIGGER. BOLDER. MORE." . That's how Good MedTech News describes the latest edition of the "MedTech Opinion Leader" magazine featuring a "dream team" of innovators driving medtech forward. 🙌 We're honored to see our CEO, Rob Krummen, featured alongside other trailblazers,

🙌 News 🙌 — @BHLexington has enrolled the first patients in the IMPRoVED-AF study. This prospective, randomized, multi-center study will evaluate the clinical benefit of using hashtag#vMap, our FDA-cleared, non-invasive arrhythmia analysis tool, to guide ablation strategies

Independence Day is a celebration of the courage, bravery, and dedication that drives progress in our country and beyond. Wishing everyone a safe and joyful 4th of July filled with connection, celebration, and the freedom to enjoy what matters most!

Vektor Medical is proud to sponsor the upcoming "EP Leadership Foundations: Building a Successful Practice" conference, happening August 8–10 in Austin, Texas. This unique event is designed specifically for EP fellows and early attendings, combining simulation labs, recorded

Cardiac arrhythmias affect millions of patients worldwide. At Vektor Medical, we’re using technology developed with AI to enhance the accuracy and efficiency of ablation procedures, helping physicians to streamline workflows, deliver improved outcomes, and expand patient access

Summer Fridays. a perfect time for on-demand, accredited CME???!!. You can still access the Rhythm Interventions Online 2024 session, “The Importance of Trigger Mapping in AF and VT,” featuring Dr. Devi G Nair, Dr. Atul Verma, Dr. Ben D’Souza, and Dr. Anish Amin here:.

vMap enables physicians to rapidly and accurately locate source locations for both focal and fibrillation-type arrhythmias. Accurate driver localization → Increased ablation accuracy.Shorter procedure times → Improved efficiency in the EP lab.Noninvasive insights → Faster

25% of adults over 40 will develop a serious cardiac arrhythmia, increasing the risk of death, stroke, and dementia. The challenge is immense. We're committed to being part of the solution. #vMap #medtech #cardiology #eplab

The treatment of arrhythmias is incredibly complex. Often made more challenging by the lack of actionable information. That's where vMap makes a difference. In this 𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗜𝗻𝘀𝗶𝗴𝗵𝘁 segment, Vektor CEO Rob Krummen shares how empowering physicians with

Vektor team members hit the beach last week for a cleanup day at Ocean Beach with The Surfrider Foundation, a group dedicated to protecting our oceans, waves, and beaches. 🌊. It was a great opportunity to make a positive impact on our local environment and to connect as a team

At Vektor, we're committed to empowering EPs with actionable insights that can improve ablation outcomes. We recently launched the IMPRoVED AF study, a prospective, multi-center RCT comparing outcomes of PVI alone vs. PVI plus vMap-guided driver ablation. As the only

Electrophysiologists rely on accuracy and efficiency to optimize patient outcomes. #vMap offers a groundbreaking approach to noninvasive arrhythmia analysis, delivering actionable insights directly from a standard 12-lead ECG. Utilizing a comprehensive arrhythmia simulation

🫀“Without tools like vMap, we’re flying blind.” — @AnishAminEP 🫀. In today’s 𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗜𝗻𝘀𝗶𝗴𝗵𝘁 segment, Dr. Anish Amin shares how #vMap is helping electrophysiologists identify arrhythmia sources, better understand complex cases, and approach ablation with

🏆 We’re honored to be recognized!🏆. Earlier this month in Chattanooga, our CEO Rob . Krummen attended a standout biotech event hosted by @SolasBio, where Vektor was awarded the 2025 Solas BioVentures Award for “impactful and innovative use of AI, revolutionizing operations with

Missed the #AI & PFA Rhythm Theater at #HRS2025?. Here’s another chance. BYOCoffee this time. No badge. No crowd. Just insights. In this full session replay, expert EPs — @Drdevignair , Dr. @AnishAminEP, Dr. Gery Tomassoni, and Dr. Ben D'Souza — break down how AI-powered ECG.

RT @MPOmagazine: Post-market study of @VektorMedical's AI-powered #Afib identification underway: .

vMap is setting a new standard for noninvasive arrhythmia analysis using AI-powered mapping. #vMap #eplab #cardiology #afib #medtech

Innovation starts with potential. The true measure is what it delivers in practice. 🫀“We're always looking for more pieces of information to drive our ablation strategies. vMap has been a really powerful tool in our EP lab.”🫀. In today’s 𝗨𝗻𝗹𝗼𝗰𝗸𝗶𝗻𝗴 𝗜𝗻𝘀𝗶𝗴𝗵𝘁